Pricing Log in Create free account
Friday 6 November 2026 Export LNTH’s income statement to Excel — free account

Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.

Revenue
+1.54%
EPS
−17.1%
Free cash flow
+7.71%
Total debt
+0.52%

Quarter to September 2026, against a year earlier

100.76 0.38 −0.38%
Market cap
$6.6B
P/E
24.3×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
4.25
Beneish M
−2.23
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Lantheus Holdings, Inc. (LNTH) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Lantheus Holdings, Inc. (LNTH) trades at a P/B ratio of 4.9×. Over the past ten years it has ranged from 0.0× (December 2017) to 38.9× (January 2018); the current reading is higher than 51% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.8× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 4.1× (27.57%)
FY2024 5.7× 7.77%
FY2023 5.3× (31.97%)
FY2022 7.8× 84.87%
FY2021 4.2× 195.59%
FY2020 1.4× (79.65%)
FY2019 7.0× (17.20%)
FY2018 8.4× (74.93%)
FY2017 33.6× —
FY2016 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 4.8× (13.01%)
Jun 2026 5.5× 36.05%
Mar 2026 4.1× (1.72%)
Dec 2025 4.1× 33.77%
43 more quarters

Against its own ten years

Low 0.0× High 38.9×
Ten-year median 4.8×
Current reading's percentile 36

P/B ratio against peers

Company P/B ratio
SUPN Indivior Pharmaceuticals Inc. compare n/m
RDY Dr. Reddy's Laboratories Ltd compare 3.0×
ALKS Alkermes plc compare 4.0×
LNTH Lantheus Holdings, Inc. 4.9×
KNSA Kiniksa Pharmaceuticals International, plc compare 9.7×
AMLX Amylyx Pharmaceuticals, Inc. compare 12.9×
HIMS Hims & Hers Health, Inc. compare 17.2×
LQDA Liquidia Corporation compare 20.4×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 59.5×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on LNTH